webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

m-PEG8-COOH

  CAS No.: 1093647-41-6   Cat No.: BADC-00889   Purity: ≥95% 4.5  

m-PEG8-COOH offers a longer PEG linker with terminal carboxylic acid functionality, facilitating controlled payload attachment in ADC synthesis. It improves hydrophilicity and stability of bioconjugates, enhancing pharmacokinetic profiles.

m-PEG8-COOH

Structure of 1093647-41-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C18H36O10
Molecular Weight
412.47
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
mPEG7-propionic acid; m-PEG8-acid; 4,7,10,13,16,19,22,25-Octaoxahexacosanoic acid; mPEG7-CH2CH2COOH; 2,5,8,11,14,17,20,23-Octaoxahexacosan-26-oic acid; MPEG7-OCH2CH2COOH
IUPAC Name
3-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOCCC(=O)O
InChI
InChI=1S/C18H36O10/c1-21-4-5-23-8-9-25-12-13-27-16-17-28-15-14-26-11-10-24-7-6-22-3-2-18(19)20/h2-17H2,1H3,(H,19,20)
InChIKey
JHUSQXBQANBSDC-UHFFFAOYSA-N
Density
1.111±0.06 g/cm3 (Predicted)
Solubility
Soluble in DCM, DMF, DMSO, Water
Flash Point
164.2±23.6 °C
Index Of Refraction
1.456
Vapor Pressure
0.0±2.8 mmHg at 25°C
Appearance
Pale Yellow Oily Liquid
Shipping
Room temperature
Storage
Store at 2-8°C
Boiling Point
503.0±50.0 °C at 760 mmHg

m-PEG8-COOH, a derivative of polyethylene glycol showcasing a carboxylic acid functional group, finds extensive utility across varied scientific and industrial domains. Here are four key applications of m-PEG8-COOH:

Drug Delivery: The versatile m-PEG8-COOH molecule assumes a pivotal role in enhancing drug delivery systems by boosting the solubility and stability of therapeutic compounds. Through conjugation of drugs to this molecular entity, pharmaceutical formulations achieve prolonged circulation in the bloodstream, thereby amplifying the bioavailability and efficacy of treatments.

Bioconjugation: Within the bioconjugation methodologies, m-PEG8-COOH emerges as a critical linker for binding biomolecules such as proteins or peptides to serve a myriad of biotechnological and therapeutic objectives. The reactive carboxylic group acts as a catalyst for coupling reactions, facilitating the creation of robust conjugates that enhance protein stability and mitigate immunogenic responses in clinical contexts. This utilization underscores the significance of m-PEG8-COOH in propelling advancements in bioconjugation technologies.

Surface Modification: Unleashing the potential of m-PEG8-COOH, surfaces including nanoparticles can undergo intelligent modifications to boost biocompatibility and deter nonspecific interactions. Coating surfaces with this molecular entity enables researchers to restrict protein adsorption and prevent unwanted cell adhesion, particularly advantageous in the development of cutting-edge biomedical devices and diagnostic assays. This application highlights the pivotal role played by m-PEG8-COOH in refining surface modification strategies.

Polymer Chemistry: m-PEG8-COOH emerges as a fundamental building block for crafting amphiphilic polymers tailored to a plethora of applications. These polymers have the capability to self-assemble into micelles or hydrogels, making them ideal candidates for drug delivery systems and tissue engineering endeavors. The integration of m-PEG8-COOH allows for meticulous adjustments of polymer properties, encompassing hydrophilicity and mechanical strength, underscoring its significance in fueling innovations within polymer chemistry.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methyltetrazine-PEG4-hydrazone-DBCO | Methyltetrazine-PEG4-SS-PEG4-methyltetrazine | Amino-PEG5-alcohol | Amino-PEG4-propionic acid | Amino-PEG2-propionic acid | Methyltetrazine-PEG4-aldehyde | Anetumab ravtansine | Maytansinoid B | Fmoc-PEG4-NHS ester | t-Boc-N-amido-PEG7-alcohol | m-PEG8-COOH
Send Inquiry
Verification code
Inquiry Basket